Algo version: 0.98b
RAIN is listed at the NASDAQ Exchange
RAIN [RAIN]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is RAIN stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Rain Therapeutics Inc. 10 years ago, but if you had invested on Friday 23rd of April 2021 when the price was $15.80, you would have made a loss of $-14.59 per share or -92.34%

No, the average daily trading liquidity for Rain Therapeutics Inc. is $290 552 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Rain Therapeutics Inc. has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Rain Therapeutics Inc. to be medium [0.6 out of 1]